Abstract
CLI120-001 Phase Ib Study of RVU120(SEL120) in Patients with AML and High Risk MDS: Updated Safety/Efficacy Results from Initial Dose Escalation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have